Positioning Australian medtech companies for local health procurement opportunities
MTPConnect has selected seven Victorian near-market and market-ready medtech companies to join the 2026 cohort of the Pathway to Market – Medtech Capability Uplift Program.
The companies are addressing critical healthcare challenges spanning infection prevention, chronic disease management, AI-enabled patient monitoring, medication safety and advanced diagnostics.
The announcement was made today at the program’s kick-off event, MTPConnect’s Medtech Selling to Health Masterclass, bringing together senior hospital clinicians, procurement leaders and health system stakeholders to provide practical guidance to companies on procurement challenges.
MTPConnect CEO Stuart Dignam said the program is about giving Australian innovators the opportunity to get more home-grown medtech products purchased and used by local hospitals and health services.
“For many medtech SMEs, entering the local health market remains complex and resource intensive. We also know that being “procurement ready” requires more than just a strong product,” Mr Dignam said.
“This is the second year we have rolled out our sought-after Pathway to Market Program which provides capability assessments, tailored practical workshops and expert insights to help SMEs get ready to navigate the Victorian Government’s procurement pathway.
“Victoria serves as the pilot state for this important, solutions-driven program, and it’s great to have the support of the Victorian Government on this initiative. This is setting the foundation to drive a national agenda for medtech innovation and manufacturing and we hope to be rolling this out in other jurisdictions,” he said.
Cohort 2026 companies selected for the Pathway to Market Program:
The Masterclass event is being held at the Victorian Heart Hospital within the Monash Technology Precinct hosted by Velos Accelerator.
The Pathway to Market program is an initiative of the Australian Medtech Manufacturing Alliance (AMMA), delivered by MTPConnect in partnership with BioMelbourne Network and supported by the Victorian Government.